Literature DB >> 8462797

Developmental expression of the gastrin and cholecystokinin genes in rat colon.

H R Lüttichau1, W W Van Solinge, F C Nielsen, J F Rehfeld.   

Abstract

BACKGROUND: To elucidate the hypothesis that gastrin and cholecystokinin (CCK) are local growth factors for colorectal mucosa, we have examined the peptide gene expression in rat colon during development.
METHODS: Northern analysis, reverse transcription PCR, and sequence-specific radioimmunoassays were the essential methods.
RESULTS: High concentrations of gastrin and CCK messenger RNA were found in the fetal colon. At birth, gastrin and CCK mRNA's were both undetectable but increased subsequently towards adult life. The fetal colon contained 5.5 and 4.2 pmol/g tissue gastrin and CCK, respectively. After birth, carboxyamidated gastrin disappeared from the colon, whereas the concentration of CCK remained at 1 pmol/g. Glycine-extended gastrin and CCK were also present in the fetal colon, but towards adult life they decreased below 0.2 pmol/g. In contrast, progastrin and proCCK were detectable at all ages.
CONCLUSIONS: Rat colon expresses the gastrin and CCK genes throughout life. The posttranslational maturation of progastrin, however, ceases shortly after birth, indicating that gastrin may play a role in the developing colon. Whether CCK influences the development remains to be shown.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462797     DOI: 10.1016/0016-5085(93)90278-k

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation.

Authors:  T J Koh; G J Dockray; A Varro; R J Cahill; C A Dangler; J G Fox; T C Wang
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  The endoproteolytic maturation of progastrin and procholecystokinin.

Authors:  Jens F Rehfeld
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

3.  Glucagon-like peptide 1 content of intestinal tract in adult rats injected with streptozotocin either during neonatal period or 7 d before sacrifice.

Authors:  Jesús Cancelas; Verónica Sancho; Maria L Villanueva-Peñacarrillo; Philippe Courtois; Fraser W Scott; Isabel Valverde; Willy J Malaisse
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.

Authors:  T J Koh; C J Bulitta; J V Fleming; G J Dockray; A Varro; T C Wang
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.

Authors:  R K Siddheshwar; J C Gray; S B Kelly
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 6.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

7.  Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.

Authors:  Isabel Valverde; Gen-Sheng Wang; Karolina Burghardt; Lisa M Kauri; Araceli Redondo; Alicia Acitores; Maria L Villanueva-Peñacarrillo; Philippe Courtois; Abdullah Sener; Jesús Cancelas; Willy J Malaisse; Fraser W Scott
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

8.  Molecular Characterization of Constipation Disease as Novel Phenotypes in CRISPR-Cas9-Generated Leptin Knockout Mice with Obesity.

Authors:  Ji Eun Kim; Yun Ju Choi; Su Jin Lee; Jeong Eun Gong; Yong Lim; Jin Tae Hong; Dae Youn Hwang
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

Review 9.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Post-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanism.

Authors:  J F Rehfeld; C P Hansen; A H Johnsen
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.